Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
38.82 USD | +1.41% | -0.49% | -15.55% |
Business Summary
Number of employees: 226
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Therapeutics
100.0
%
| 24 | 100.0 % | 77 | 100.0 % | +227.56% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
80.6
%
| 24 | 100.0 % | 62 | 80.6 % | +164.09% |
Other
11.5
%
| - | - | 9 | 11.5 % | - |
Germany
7.8
%
| - | - | 6 | 7.8 % | - |
Managers
Managers | Title | Age | Since |
---|---|---|---|
David Meeker
CEO | Chief Executive Officer | 69 | 31/10/15 |
Hunter Smith
DFI | Director of Finance/CFO | 56 | 30/06/17 |
Joseph Shulman
CTO | Chief Tech/Sci/R&D Officer | 49 | 26/07/20 |
Dana Washburn
CTO | Chief Tech/Sci/R&D Officer | 61 | 25/09/22 |
David Connolly
IRC | Investor Relations Contact | - | 30/04/19 |
Comptroller/Controller/Auditor | 53 | 28/02/23 | |
Corporate Officer/Principal | - | 31/03/21 | |
Pamela Cramer
HRO | Human Resources Officer | 50 | 25/07/21 |
Jim Flaherty
LAW | General Counsel | - | 30/06/19 |
Yann Mazabraud
PRN | Corporate Officer/Principal | 51 | 04/10/20 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Christophe Jean
BRD | Director/Board Member | 67 | 31/03/15 |
Jennifer Good
BRD | Director/Board Member | 59 | 18/06/19 |
David McGirr
BRD | Director/Board Member | 69 | 31/10/15 |
Director/Board Member | 71 | 08/12/20 | |
Director/Board Member | 64 | 20/03/13 | |
David Meeker
CEO | Chief Executive Officer | 69 | 31/10/15 |
Lynn Tetrault
BRD | Director/Board Member | 61 | 08/12/20 |
Stuart Arbuckle
BRD | Director/Board Member | 58 | 23/07/19 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 60,963,518 | 57,367,172 ( 94.10 %) | 0 | 94.10 % |
Company contact information
Rhythm Pharmaceuticals, Inc.
222 Berkeley Street 12th floor
02116-3748, Boston
+857 264 4280
http://www.rhythmtx.comSector
Sales per region
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-15.55% | 2.33B | |
-2.63% | 103B | |
+1.62% | 95.28B | |
+1.46% | 22.15B | |
-16.67% | 21.02B | |
-8.58% | 18.15B | |
-38.74% | 16.73B | |
-13.21% | 16.05B | |
+5.41% | 13.68B | |
+33.57% | 12.17B |
- Stock Market
- Equities
- RYTM Stock
- Company Rhythm Pharmaceuticals, Inc.